← Back to search

AMICUS THERAPEUTICS, INC.

FOLD · NASDAQ

Pharmaceutical Preparation Manufacturing

Amicus Therapeutics is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare metabolic diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a robust pipeline of cutting-edge, first- or best-in-class medicines for rare metabolic diseases.

ESG Scores

Overall ESG
2.5
Environmental
2.6
Social
3.2
Governance
4.8

Gender Diversity

Female Directors0.3%
Female Executives0.22514071294559101%
CEO GenderMale

Market Data

Price$14.46+0.00 (+0.00%)
Market Cap$4.54B
P/E Ratio
EPS$—
52W High$14.48
52W Low$5.51
Beta0.44